Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT07407959

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Led by Mayo Clinic · Updated on 2026-02-17

60

Participants Needed

1

Research Sites

160 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study evaluates whether newly developed non-FDA approved image processing techniques \[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\] can provide improved quality and decreased time compared to current scanning techniques.

CONDITIONS

Official Title

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over the age of 18
  • For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy
  • For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical)
Not Eligible

You will not qualify if you...

  • Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures/conditions for scanning, pregnant people, individuals with implanted metal, etc.)
  • Patient under the age of 18
  • Patient who is unable to consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials Referral Office

CONTACT

B

Bobbie Ott

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here